WHO ICTRP trial

Research on the Protective Effect and Underlying Mechanism of ciprofol…

ChiCTR2500108096 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting

Key facts

Trial ID ChiCTR2500108096
Public title Research on the Protective Effect and Underlying Mechanism of ciprofol preconditioning on hepatic ischemia-reperfusion injury
Scientific title Research on the Protective Effect and Underlying Mechanism of ciprofol preconditioning on hepatic ischemia-reperfusion injury
Primary sponsor The Second Affiliated Hospital of Shandong First Medical University
Registry Chinese Clinical Trial Registry (ChiCTR)
Recruitment status Not Recruiting
Study type Interventional study
Countries China
Conditions Hepatic ischemia-reperfusion injury
Interventions Ciprofol pre-treatment group:General anesthesia was induced and maintained with conventional anesthetic drugs. Thirty minutes before reperfusion, 0.4 mg/kg of ciprofol was intravenously infused over 30 minutes while reducing the inhalation…
Registration date Aug 25, 2025
Target size Ciprofol pre-treatment group:30;Control group:30
Registry page chictr.org.cn

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations